These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 22907703)

  • 1. Ras homolog gene family, member A promotes p53 degradation and vascular endothelial growth factor-dependent angiogenesis through an interaction with murine double minute 2 under hypoxic conditions.
    Ma J; Xue Y; Cui W; Li Y; Zhao Q; Ye W; Zheng J; Cheng Y; Ma Y; Li S; Han T; Miao L; Yao L; Zhang J; Liu W
    Cancer; 2012 Sep; 118(17):4105-16. PubMed ID: 22907703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
    Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of RhoA in hypoxia-induced breast cancer cell VEGF secretion and proliferation, migration and tube formation of HUVECs].
    Ma J; Zhao Q; Ren H; Liu W; Xue Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):784-8. PubMed ID: 22699054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of activated Rac1/Cdc42 in mediating endothelial cell proliferation and tumor angiogenesis in breast cancer.
    Ma J; Xue Y; Liu W; Yue C; Bi F; Xu J; Zhang J; Li Y; Zhong C; Chen Y
    PLoS One; 2013; 8(6):e66275. PubMed ID: 23750283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of murine double minute-2 on Ser166 is downstream of VEGF-A in exercised skeletal muscle and regulates primary endothelial cell migration and FoxO gene expression.
    Aiken J; Roudier E; Ciccone J; Drouin G; Stromberg A; Vojnovic J; Olfert IM; Haas T; Gustafsson T; Grenier G; Birot O
    FASEB J; 2016 Mar; 30(3):1120-34. PubMed ID: 26578686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of p53 and MDM2 inhibitor RG7388 using a hydroxyl terminal PAMAM dendrimer derivative for synergistic cancer therapy.
    Chen K; Xin X; Qiu L; Li W; Guan G; Li G; Qiao M; Zhao X; Hu H; Chen D
    Acta Biomater; 2019 Dec; 100():118-131. PubMed ID: 31568878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway.
    Zauli G; Rimondi E; Corallini F; Fadda R; Capitani S; Secchiero P
    J Bone Miner Res; 2007 Oct; 22(10):1621-30. PubMed ID: 17592964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhein inhibits angiogenesis and the viability of hormone-dependent and -independent cancer cells under normoxic or hypoxic conditions in vitro.
    Fernand VE; Losso JN; Truax RE; Villar EE; Bwambok DK; Fakayode SO; Lowry M; Warner IM
    Chem Biol Interact; 2011 Jul; 192(3):220-32. PubMed ID: 21457705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells.
    Hauke M; Eckenstaler R; Ripperger A; Ender A; Braun H; Benndorf RA
    J Am Heart Assoc; 2022 Jun; 11(12):e025119. PubMed ID: 35699166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway.
    Kumar B; Chile SA; Ray KB; Reddy GE; Addepalli MK; Kumar AS; Ramana V; Rajagopal V
    Angiogenesis; 2011 Sep; 14(3):371-80. PubMed ID: 21698469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells.
    Endo S; Yamato K; Hirai S; Moriwaki T; Fukuda K; Suzuki H; Abei M; Nakagawa I; Hyodo I
    Cancer Sci; 2011 Mar; 102(3):605-13. PubMed ID: 21205074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha.
    Lee YM; Lim JH; Chun YS; Moon HE; Lee MK; Huang LE; Park JW
    Carcinogenesis; 2009 Oct; 30(10):1768-75. PubMed ID: 19696166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer.
    Xiong J; Li J; Yang Q; Wang J; Su T; Zhou S
    Breast Cancer Res; 2017 Mar; 19(1):27. PubMed ID: 28274247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
    Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
    Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation.
    Thirusangu P; Vigneshwaran V; Prashanth T; Vijay Avin BR; Malojirao VH; Rakesh H; Khanum SA; Mahmood R; Prabhakar BT
    Angiogenesis; 2017 Feb; 20(1):55-71. PubMed ID: 27743086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
    Medeiros PJ; Jackson DN
    Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.
    Drakos E; Thomaides A; Medeiros LJ; Li J; Leventaki V; Konopleva M; Andreeff M; Rassidakis GZ
    Clin Cancer Res; 2007 Jun; 13(11):3380-7. PubMed ID: 17545546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.